The Science Behind Food and Chemical Sensitivity Testing Sponsored by PERQUE Integrative Health

By Russell M. Jaffe, MD, PhD

September 30, 2019

Today, at least 1 out of every 6 Americans, or 40 million people in the United States, suffer from one or more autoimmune and immune dysfunction diseases. As a result, chronically ill Americans spend over $300 billion per year directly for autoimmune syndrome treatments that often do not reduce their suffering or improve their health.

Our immune system is designed to defend during the day and repair at night. When this pattern is upset, we enter a cycle of repair deficit (lack of repair) resulting in an overburdened immune system. An overburdened immune system can mean that our innate immune system may not be able to protect us from foreign invaders. Having an intolerant immune system can result in chronic disease, weak digestion, fatigue, skin issues, and much more.

Integrative healthcare practitioners see the health consequences of an overburdened, intolerant immune system every day.

That’s why I developed the patented LRA (LRA by ELISA/ACT™) tests and treatment plan in 1984. The advanced test method enables physicians to quickly and precisely determine the hidden causes of many chronic conditions and help their patients find sustained relief. By looking directly at lymphocytes, the LRA detects all 3 types of delayed food and chemical hypersensitivities up to as many as 512 items.

If you’re already using food & chemical sensitivity testing (or completely new to functional immune testing) and would like to understand the differences between the LRA test and others you’re familiar with watch this FREE Webinar. You will learn about:

  • The science behind delayed hypersensitivity reactions.
  • The various types of tests used to identify delayed reactions- what they measure and how they differ.
  • How ex vivo lymphocyte response assays precisely and accurately detect all 3 types of delayed immune responses.

Get Details and Register Here

About the Author

Russell M. Jaffe, MD, PhD, is CEO and Chairman of PERQUE Integrative Health (PIH). He is considered one of the pioneers of integrative and regenerative medicine. Since inventing the world’s first single step amplified (ELISA) procedure in 1984, a process for measuring and monitoring all delayed allergies, Jaffe has continually sought new ways to help speed the transition from our current healthcare system’s symptom reactive model to a more functionally integrated, effective, and compassionate system. PIH is the outcome of years of Jaffe’s scientific research. It brings to market 3 decades of rethinking safer, more effective, novel, and proprietary dietary supplements, supplement delivery systems, diagnostic testing, and validation studies.